Original Literature | Model OverView |
---|---|
Publication
Title
Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellularsaboteurs.
Affiliation
Cornell University Medical College, New York, New York 10021 and UCLA School ofMedicine, Los Angeles, California 90095, USA.
Abstract
During the pathogenesis of atherosclerosis, inflammatory cells such as themonocyte-derived macrophage accumulate in the vessel wall where they releasecytokines. Initially, cytokines may assist in CE removal of lipoprotein-derivedcholesterol/CE hydrolysis to clear intracellular lipid. When plasma levels ofLDL become elevated, the vessel wall becomes lipid-engorged over time because itis unable to traffick the large amounts of endocytosed LDL-CE from the cell. Inaddition, lipoprotein entrapment by the extracellular matrix can lead to theprogressive oxidation of LDL because of the action of lipoxygenases, reactiveoxygen species, peroxynitrite, and/or myeloperoxidase. A range of oxidized LDLspecies is thus generated, ultimately resulting in their delivery to vascularcells through several families of scavenger receptors (Fig 1). These molecularTrojan horses and cellular saboteurs once formed or deposited in the cell cancontribute to, and participate in, formation of macrophage- and smoothmuscle-derived foam cells. A lipid-enriched fatty streak along the vessel wallcan ensue. In addition to foam cell development, products of LDL peroxidationmay activate endothelial cells, increase smooth muscle mitogenesis, or induceapoptosis because of the effects of oxysterols and products of lipidperoxidation (Fig 1). Because antioxidant defenses may be limited in themicroenvironment of the cell or within LDL, the oxidation process continues toprogress. Enzymes associated with HDL such as PAF acetylhydrolase andparaoxonase can participate in the elimination of biologically active lipids,but diminished cellular antioxidant activity coupled with low levels of HDL mayallow acceleration of the clinical course of vascular disease. There is stillmuch to be learned about how modified LDL initiate cellular signals that lead toinflammation, mitosis, or cholesterol accumulation. The present challengesinclude elucidation of the key signaling events that regulatelipoprotein-derived cholesterol trafficking in the vessel wall, which can impacton the pathogenesis of vascular disease.
PMID
9287290
|
Entity
M-CSF
--
MO000000100
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m89
10
infinite
0
InterPro | IPR008001 |
TRANSPATH | MO000000100 |
--
IL-1
--
MO000000214
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m185
10
infinite
0
TRANSPATH | MO000000214 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
LDL
--
MO000000290
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m290118
10
infinite
0
TRANSPATH | MO000000290 |
--
TGFbeta
--
MO000016808
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1746
10
infinite
0
TRANSPATH | MO000016808 |
--
LDL receptor
--
MO000061802
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36695
10
infinite
0
TRANSPATH | MO000061802 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
apoE containing HDL
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
apoE receptor: apoE containing HDL
--
e12
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
SR-AI
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
SR-AII
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
Acetylated LDL:SR-AI
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
Oxidized LDL
--
e17
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17
10
infinite
0
TRANSPATH | MO000000290 |
--
Oxidized LDL:SR-AI
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
Fucoidan
--
e19
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
Fucoidan:SR-AI
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
Carrageenan
--
e21
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
Carrageenan:SR-AI
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
SR-AII:Acetylated LDL
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
Oxidized LDL:SR-AII
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
Fucoidan:SR-AII
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m25
0
infinite
0
--
Carrageenan:Sr-AII
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
CD36
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
Oxidized LDL:CD36
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
Anionic Phospholipids
--
e29
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Anionic Phospholipids:CD36
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
SR-B1
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
Oxidized LDL:SR-B1
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
Anionic Phospholipids:SR-B1
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
Basic fibroblast growth factor
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
csml-variable:Double
m35
0
infinite
0
--
mm-LDL:LDL receptor
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
Oxidized LDL
--
e38
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38
10
infinite
0
TRANSPATH | MO000000290 |
--
CD68
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
CD68:Oxidized LDL
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m40
0
infinite
0
--
apoE containing HDL
--
e41
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m41
0
infinite
0
--
mm-LDL
--
e43
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m43
10
infinite
0
TRANSPATH | MO000000290 |
--
Inflammatory cytokines
--
e44
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m44
0
infinite
0
--
Inflammatory cytokines
--
e45
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m45
0
infinite
0
--
csml-variable:Double
m46
0
infinite
0
--
Chemokines
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
Growth factors
--
e49
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m49
0
infinite
0
--
LDL:LDL receptor
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
apoE receptor
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
Monocyte specific adhesion molecule
--
e63
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
M-CSF
--
e64
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m64
0
infinite
0
--
Tissue factor
--
e65
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m65
0
infinite
0
--
Tissue factor
--
e66
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m66
0
infinite
0
--
SR-AI
--
e67
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
Specific class A scavenger receptor ligand
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
urokinase
--
e69
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
Il-1
--
e70
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
Phospholipase A2
--
e71
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
Lysophosphatidylcholine
--
e72
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
--
e73
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m73
0
infinite
0
--
--
e74
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m74
0
infinite
0
--
--
e75
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m75
0
infinite
0
--
--
e76
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m76
0
infinite
0
--
--
e77
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m77
0
infinite
0
--
--
e78
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m78
0
infinite
0
--
--
e79
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m79
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e80
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e81
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m81
0
infinite
0
--
--
e82
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m82
0
infinite
0
--
--
e83
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m83
0
infinite
0
--
--
e84
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m84
0
infinite
0
--
--
e85
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m85
0
infinite
0
--
Smooth muscle/fibroblast growth factor
--
e86
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m86
0
infinite
0
--
Heparin binding growth factors
--
e87
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m88
0
infinite
0
--
PAF
--
e88
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
G protein coupled PAF receptor
--
e89
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
PAF: G protein coupled PAF receptor
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
G-proteins{active}:Phosphoinositide phospholipase C
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m94
0
infinite
0
--
G-proteins:Phosphoinositide phospholipase C
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m95
0
infinite
0
--
PAF acetylhydrolase
--
e93
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m96
0
infinite
0
--
12-hydroxyeicosatetraenoic acid
--
e94
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m97
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c43 : 1
stoichiometry:c3 : 1
m290118*m36695*m87*0.1
nodelay
--
0
PMID: 9287290,2988123 This receptor, known as the apoB,E receptor or the LDL receptor (LDL-R), is a ubiquitous cell surface transmembrane protein PMID: 9287290,7627719,1464611,7510705,8349628 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL. These mediators include PDGF,TGF-beta ,basic fibroblast growth factor, TNF-alpha and IL-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m21*m15*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m27*m17*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m27*m29*0.1
nodelay
--
0
PMID: 9287290,7538425 These receptors bind oxidized LDL, apoptotic cells, and anionic phospholipids
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m17*m31*0.1
nodelay
--
0
PMID: 9287290,7538425 These receptors bind oxidized LDL, apoptotic cells, and anionic phospholipids
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m29*m31*0.1
nodelay
--
0
PMID: 9287290,7538425 These receptors bind oxidized LDL, apoptotic cells, and anionic phospholipids
p1
p15
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c49 : 1
m290118*m36695*m1746*0.1
nodelay
--
0
PMID: 9287290,2988123 This receptor, known as the apoB,E receptor or the LDL receptor (LDL-R), is a ubiquitous cell surface transmembrane protein PMID: 9287290,7627719,1464611,7510705,8349628 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL. These mediators include PDGF,TGF-beta ,basic fibroblast growth factor, TNF-alpha and IL-1
p1
p16
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c51 : 1
stoichiometry:c50 : 1
m290118*m36695*m230*0.1
nodelay
--
0
PMID: 9287290,2988123 This receptor, known as the apoB,E receptor or the LDL receptor (LDL-R), is a ubiquitous cell surface transmembrane protein PMID: 9287290,7627719,1464611,7510705,8349628 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL. These mediators include PDGF,TGF-beta ,basic fibroblast growth factor, TNF-alpha and IL-1
p1
p17
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c55 : 1
stoichiometry:c54 : 1
m290118*m36695*m185*0.1
nodelay
--
0
PMID: 9287290,2988123 This receptor, known as the apoB,E receptor or the LDL receptor (LDL-R), is a ubiquitous cell surface transmembrane protein PMID: 9287290,7627719,1464611,7510705,8349628 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL. These mediators include PDGF,TGF-beta ,basic fibroblast growth factor, TNF-alpha and IL-1
p1
p18
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
stoichiometry:c59 : 1
stoichiometry:c58 : 1
m290118*m36695*m34*0.1
nodelay
--
0
PMID: 9287290,2988123 This receptor, known as the apoB,E receptor or the LDL receptor (LDL-R), is a ubiquitous cell surface transmembrane protein PMID: 9287290,7627719,1464611,7510705,8349628 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL. These mediators include PDGF,TGF-beta ,basic fibroblast growth factor, TNF-alpha and IL-1
p19
p19
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c62 : 1
stoichiometry:c61 : 1
m35*m290118*0.1
nodelay
--
0
PMID: 9287290,3571245 LDL can also directly stimulate PDGF production in endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m11*m6*0.1
nodelay
--
0
PMID: 9287190 Another important receptor is the apoE receptor found principally in hepatic cells and macrophages. It is mainly responsible for the binding and internalization of chylomicron remnants as well as apoE-containing HDL
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m290118*0.1
nodelay
--
0
PMID: 9287290 LDL entrapped within the arterial wall can undergo progressive oxidation producing minimally oxidized LDL particles (mm-LDL) or molecular Trojan horses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m36*m36695*0.1
nodelay
--
0
PMID: 9287290,7729036 These molecular Trojan horses, like plasma LDL, can bind to the LDL-R but, unlike native LDL, bear a cargo of biologically active products of lipid peroxidation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m18*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m32*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m24*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m28*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m17*m39*0.1
nodelay
--
0
PMID: 9287290,8962141 A third class of scavenger receptors has been reported recently by Steinberg and colleagues to be macrosialin/CD68, a family of endosomal proteins with sequence homology similar to the lysosomal-associated membrane proteins.The role of these lysosomal-associated membrane proteins in the uptake of oxidized LDL during atherogenesis remains to be elucidated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m40*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m12*0.1
nodelay
--
0
PMID: 9287190 Another important receptor is the apoE receptor found principally in hepatic cells and macrophages. It is mainly responsible for the binding and internalization of chylomicron remnants as well as apoE-containing HDL
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m5*0.1
nodelay
--
0
PMID: 9287290 Inflammatory mediators such as growth factors and cytokines can promote the binding and uptake of LDL.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m13*m14*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
p22
p30
cso30:i:ME_Internalization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m37*0.1
nodelay
--
0
PMID: 9287190 The uptake of these "cellular saboteurs" not only produces internalization of bioactive macromolecules and lipid peroxide products but also facilitates lipoprotein-derived CE accumulation characteristic of arterial "foam" cell formation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c101 : 1
stoichiometry:c96 : 1
m44*m38*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c105 : 1
stoichiometry:c98 : 1
m46*m38*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c108 : 1
stoichiometry:c100 : 1
m48*m43*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c104 : 1
stoichiometry:c103 : 1
m44*m43*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c109 : 1
stoichiometry:c107 : 1
m43*m46*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c112 : 1
stoichiometry:c111 : 1
m48*m38*0.1
nodelay
--
0
PMID: 9297290 Finally, lipid peroxidation products borne by molecular Trojan horses and cellular saboteurs can activate the cell to produce inflammatory cytokines, chemokines, or growth factors, which can deliver cholesterol/CE to the cell by enhancing the expression of lipoprotein receptors, resulting in the eventual cellular engorgement of cholesterol.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m38*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m43*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m38*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m13*m17*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m43*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m64*m38*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m43*m64*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c129 : 1
stoichiometry:c128 : 1
m66*m38*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m43*m66*0.1
nodelay
--
0
PMID: 9287290,8673557 The cellular acquisition of bioactive lipids induces endothelial cell responses predisposing to atherogenesis, and these include the ability to induce expression of monocyte-specific adhesion molecules, expression of the monocyte chemoattractant protein-1, synthesis of monocyte colony-stimulating factor (M-CSF), and tissue factor production
p45
p45
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c133 : 1
m89*0.1
nodelay
--
0
PMID: 9287290,1727858,2114402,1744079,1739124 In addition, it has now been shown that macrophage Class A scavenger receptors are down-regulated by TNF-alpha,, IFN-gamma,, TGF-beta , and lipopolysaccharide but up-regulated by M-CSF
p46
p46
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m89*0.1
nodelay
--
0
PMID: 9287290,8634453 Expression of CD36, a Class B scavenger receptor, which is responsible for a significant quantity of oxidized LDL binding and uptake by macrophages in vitro is also increased by M-CSF
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c148 : 1
stoichiometry:c142 : 1
m68*m92*0.1
nodelay
--
0
PMID: 9287290,1658006,1663075,7683591 Specific Class A scavenger receptor ligands stimulate macrophage urokinase expression , IL-1 production, and expression in a PKC-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c147 : 1
stoichiometry:c144 : 1
m68*m92*0.1
nodelay
--
0
PMID: 9287290,1658006,1663075,7683591 Specific Class A scavenger receptor ligands stimulate macrophage urokinase expression , IL-1 production, and expression in a PKC-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
m70*0.1
nodelay
--
0
PMID: 9287290,1658006,1663075,7683591 Specific Class A scavenger receptor ligands stimulate macrophage urokinase expression , IL-1 production, and expression in a PKC-dependent manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m13*m19*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
m71*0.1
nodelay
--
0
PMID: 9287290,3357891 One well studied, stable end product includes lysophosphatidylcholine, which is generated by phospholipase A2 hydrolysis during cellular oxidative modification of LDL
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,1381720 This lipid selectively induces the expression of adhesion molecules for monocytes, vascular cell adhesion molecule-I (VCAM-I), and ICAM-1 in cultured human and rabbit arterial endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,1381720 This lipid selectively induces the expression of adhesion molecules for monocytes, vascular cell adhesion molecule-I (VCAM-I), and ICAM-1 in cultured human and rabbit arterial endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,1381720 This lipid selectively induces the expression of adhesion molecules for monocytes, vascular cell adhesion molecule-I (VCAM-I), and ICAM-1 in cultured human and rabbit arterial endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,7509351 Finally, lysophosphatidylcholine induces gene expression for smooth muscle/fibroblast growth factors, the A and B chains of PDGF, and heparin-binding epidermal growth factor-like protein in cultured endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,7509351 Finally, lysophosphatidylcholine induces gene expression for smooth muscle/fibroblast growth factors, the A and B chains of PDGF, and heparin-binding epidermal growth factor-like protein in cultured endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c162 : 1
m72*0.1
nodelay
--
0
PMID: 9287290,7509351 Finally, lysophosphatidylcholine induces gene expression for smooth muscle/fibroblast growth factors, the A and B chains of PDGF, and heparin-binding epidermal growth factor-like protein in cultured endothelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c164 : 1
stoichiometry:c165 : 1
m90*m91*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m93*m95*0.1
nodelay
--
0
PMID: 9287290,8798508 Binding of PAF by the G protein-coupled PAF receptor leads to activation of heterotrimeric G proteins linked to phosphoinositide phospholipase C
p59
p59
cso30:i:ME_Oxidation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
stoichiometry:c170 : 1
m97*m290118*0.1
nodelay
--
0
PMID: 9287290 Lipoxygenase metabolites such as 12-hydroxyeicosatetraenoic acid from the aspirin-insensitive arachidonic acid pathway can also lead to oxidation of LDL in cells. PMID: 9287290 Stafforini et al. have demonstrated that PAF acetylhydrolase prevents formation of highly oxidized LDL.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m21*m13*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m17*m70*0.1
nodelay
--
0
PMID: 9287290 In addition, oxidized LDL and mm-LDL can significantly induce the release of IL-1 from macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m36*m70*0.1
nodelay
--
0
PMID: 9287290 In addition, oxidized LDL and mm-LDL can significantly induce the release of IL-1 from macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m15*m14*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m15*m17*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m19*m15*0.1
nodelay
--
0
PMID: 9287190 Ligands for class A receptors include acetylated LDL, oxidized LDL, fucoidan, and carrageenan.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--